In these reports, while endogenous insulin secretion was preserved and the risk of insulin deficiency was low, it is recommended that treatment be carried out in accordance with the guidelines for type 2 diabetes, except for the use of sulfonylurea agents. This evidence concerns the gene INS and type 2 diabetes mellitus.